Tempus reports second quarter 2025 results

Chicago--(business wire)--tempus ai, inc. (nasdaq: tem), a technology company leading the adoption of ai to advance precision medicine and patient care, today reported financial results for the quarter ended june 30, 2025. revenue increased 89.6% year-over-year to $314.6 million in the second quarter genomics revenue increased 115.3% year-over-year to $241.8 million on accelerating year-over-year volume growth in oncology (26%) and hereditary (32%) testing data and services revenue increased 35.
TEM Ratings Summary
TEM Quant Ranking